Literature DB >> 16480042

Expression of MHC II genes.

G Drozina1, J Kohoutek, N Jabrane-Ferrat, B M Peterlin.   

Abstract

Innate and adaptive immunity are connected via antigen processing and presentation (APP), which results in the presentation of antigenic peptides to T cells in the complex with the major histocompatibility (MHC) determinants. MHC class II (MHC II) determinants present antigens to CD4+ T cells, which are the main regulators of the immune response. Their genes are transcribed from compact promoters that form first the MHC II enhanceosome, which contains DNA-bound activators and then the MHC II transcriptosome with the addition of the class II transactivator (CIITA). CIITA is the master regulator of MHC II transcription. It is expressed constitutively in dendritic cells (DC) and mature B cells and is inducible in most other cell types. Three isoforms of CIITA exist, depending on cell type and inducing signals. CIITA is regulated at the levels of transcription and post-translational modifications, which are still not very clear. Inappropriate immune responses are found in several diseases, including cancer and autoimmunity. Since CIITA regulates the expression of MHC II genes, it is involved directly in the regulation of the immune response. The knowledge of CIITA will facilitate the manipulation of the immune response and might contribute to the treatment of these diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16480042     DOI: 10.1007/3-540-26363-2_7

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  28 in total

1.  MHC class II upregulation and colocalization with Fas in experimental models of immune-mediated bone marrow failure.

Authors:  Andrew J Erie; Leigh Samsel; Tomoiku Takaku; Marie J Desierto; Keyvan Keyvanfar; J Philip McCoy; Neal S Young; Jichun Chen
Journal:  Exp Hematol       Date:  2011-05-13       Impact factor: 3.084

2.  Role of Sug1, a 19S proteasome ATPase, in the transcription of MHC I and the atypical MHC II molecules, HLA-DM and HLA-DO.

Authors:  Yaritza Inostroza-Nieves; Prasanna Venkatraman; Zarixia Zavala-Ruiz
Journal:  Immunol Lett       Date:  2012-07-04       Impact factor: 3.685

3.  Masking of a cathepsin G cleavage site in vivo contributes to the proteolytic resistance of major histocompatibility complex class II molecules.

Authors:  Timo Burster; Henriette Macmillan; Tieying Hou; James Schilling; Phi Truong; Bernhard O Boehm; Fang Zou; Kenneth Lau; Michael Strohman; Steven Schaffert; Robert Busch; Elizabeth D Mellins
Journal:  Immunology       Date:  2010-03-17       Impact factor: 7.397

4.  The zinc finger proteins ZXDA and ZXDC form a complex that binds CIITA and regulates MHC II gene transcription.

Authors:  Wafa Al-Kandari; Rupa Koneni; Vandana Navalgund; Anastasiia Aleksandrova; Srikarthika Jambunathan; Joseph D Fontes
Journal:  J Mol Biol       Date:  2007-04-19       Impact factor: 5.469

5.  B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion.

Authors:  Daniela Asslaber; Yuan Qi; Nicole Maeding; Markus Steiner; Ursula Denk; Jan Philip Höpner; Tanja Nicole Hartmann; Nadja Zaborsky; Richard Greil; Alexander Egle
Journal:  Blood       Date:  2019-11-14       Impact factor: 22.113

Review 6.  HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance.

Authors:  Barbara Seliger; Matthias Kloor; Soldano Ferrone
Journal:  Oncoimmunology       Date:  2017-02-06       Impact factor: 8.110

Review 7.  Operons.

Authors:  Anne E Osbourn; Ben Field
Journal:  Cell Mol Life Sci       Date:  2009-08-07       Impact factor: 9.261

8.  Distinct MHC gene expression patterns during progression of melanoma.

Authors:  Yan Degenhardt; Jia Huang; Joel Greshock; Galene Horiates; Katherine Nathanson; Xiaolu Yang; Meenhard Herlyn; Barbara Weber
Journal:  Genes Chromosomes Cancer       Date:  2010-02       Impact factor: 5.006

9.  Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production.

Authors:  Kousuke Saito; Malika Ait-Goughoulte; Steven M Truscott; Keith Meyer; Azra Blazevic; Getahun Abate; Ratna B Ray; Daniel F Hoft; Ranjit Ray
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

10.  RFX2 is a candidate downstream amplifier of A-MYB regulation in mouse spermatogenesis.

Authors:  Gary C Horvath; Malathi K Kistler; W Stephen Kistler
Journal:  BMC Dev Biol       Date:  2009-12-09       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.